Poll

Article

Poll: How Much Do You Know About Muscarinic Receptor Agonists?

Key Takeaways

  • KarXT is a novel muscarinic acetylcholine receptor agonist developed by Bristol Myers Squibb for schizophrenia treatment.
  • The US FDA is reviewing the New Drug Application for KarXT, focusing on its efficacy and safety.
SHOW MORE

How comfortable do you feel in your knowledge of this type of treatment?

The US Food and Drug Administration is scheduled to share results of the New Drug Application for Bristol Myers Squibb’s KarXT for the treatment of schizophrenia. KarXT is a novel muscarinic acetylcholine receptor agonist. How comfortable do you feel in your knowledge of this type of treatment? Tell us here!

How much do you know about muscarinic receptor agonists?

I feel very educated about this type of treatment.
I feel somewhat educated about this type of treatment.
I feel somewhat uneducated about this type of treatment.
I feel very uneducated about this type of treatment.

If you feel uneducated about muscarinic receptor agonists, what do you want to know? Let us know by emailing us at PTEditor@MMHGroup.com!

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
© 2025 MJH Life Sciences

All rights reserved.